These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Synthesis and certain properties of polysaccharides in B. oedematiens & B. perfringens]. IVANOV VI, VOLCHOK AK, LOBANOVA AV. Biokhimiia; 1956; 21(6):760-3. PubMed ID: 13445781 [No Abstract] [Full Text] [Related]
30. [Observations on the formation in mixed cultures of hemotoxins of Cl. perfringens and oedematiens]. Zanchevskaia TA. Zh Mikrobiol Epidemiol Immunobiol; 1964 May; 41(5):105-9. PubMed ID: 4286366 [No Abstract] [Full Text] [Related]
31. [Toxin formation by Cl. perfringens type E]. Zemlianitskaia EP, Matveev KI, Tsurikov FF. Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060 [No Abstract] [Full Text] [Related]
32. [Guinea pig diseases caused by Cl. perfringens type A]. Nedjalkov S, Draganov M, Pejtschev B. Arch Exp Veterinarmed; 1966 Apr; 20(2):323-5. PubMed ID: 4296802 [No Abstract] [Full Text] [Related]
33. [Study of the effect of Cl. sporogenes proteinases on the hemolytic activity of Cl. perfringens type A toxin]. Zhak SP, Datsenko MF. Mikrobiol Zh; 1968 Apr; 30(6):566-8. PubMed ID: 4308969 [No Abstract] [Full Text] [Related]
37. [Formation of toxins by Clostridium perfringens types C and D]. Urguev KR. Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342 [No Abstract] [Full Text] [Related]
40. The use of a multicomponent standard for clostridial vaccines. Gray AK. Dev Biol Stand; 1976 Jun; 32():245-50. PubMed ID: 187507 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]